Sitagliptin alters bone composition in high-fat-fed mice
Type 2 diabetes mellitus is recognized as a significant risk factor for fragility of bone. Among the newer anti-diabetic agents, dipeptidyl peptidase-4 inhibitors (DPP4i) have been reported to decrease the occurrence of bone fractures although the reason is unclear. The main aim of this study was to...
| Main Authors: | , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
CALCIFIED TISSUE INTERNATIONAL, Springer Link
2018
|
| Subjects: | |
| Online Access: | http://eprints.uthm.edu.my/5850/1/AJ%202018%20%28919%29%20Sitagliptin%20alters%20bone%20composition%20in%20high-fat-fed%20mice.pdf |